CANSEQ

Scientific research services; scientific and research service development, namely, development of technologies and algorithms for performing genomic analyses of patients' cancer cells and normal cells for the purposes of guiding their medical management and treatment; and scientific services, namely, scientific laboratory services in the fields of genetics, genome sequencing and cancer medicine, diseases, medical conditions and disorders, biology, and pharmaceuticals; informational services, namely, providing medical research information in the fields of medicine, diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals; medical and scientific research services, namely, identifying genetic characteristics that affect patients' likelihood or inherited risk of developing cancer and their responsiveness or resistance to cancer treatments and therapies, and the reasons for such likelihood, inherited risk or resistance, and that are useful in helping to predict the prognosis, clinical course, and likelihood of recurrence of patients' cancers, illnesses or malignancies and the effectiveness of treatments and therapies therefor

Medical services; medical services in the fields of diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals; medical services, namely, administering cancer treatments and therapies based on or that take into account the genetic characteristics or composition of patients or patients' diseases; providing medical information in the fields of medicine, diseases, medical conditions and disorders, biology, genetics, genome sequencing, and pharmaceuticals